Zynerba Pharmaceuticals Overview

Zynerba Pharmaceuticals Operating Income

Operating Income for ZYNE.

Quarterly Operating Income

$-11136207.00

↑ 21.46% YoY

As of Jun 30, 2023

Annual Operating Income (TTM)

$-38786237.00

↑ 4.49% YoY

Trailing 12 months ending Jun 30, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin